Karl Storz Endoscopy-America Inc.

Karl Storz Endoscopy-America Inc., a foreign-owned subsidiary of German-based Karl Storz GmbH & Co. KG headquartered in El Segundo, California, supplies surgical and diagnostic endoscopy equipment and accessories as a prime contractor across the federal government on full-and-open federal supply schedules, with no SBA set-aside certifications and no subcontractor engagement across its federal footprint.

The company's concrete capability portfolio centers on medical-grade endoscopy systems, optical instruments, and associated supplies. Signature product lines include Hopkins telescopes in multiple angles and magnifications, C-MAC video laryngoscopes with various blade configurations, CMOS video rhino-laryngoscopes, endoscopic video systems with 4K recording and digital documentation capabilities, specialized surgical instruments (forceps, biopsy tools, scissors, needle holders, retractors), insufflation tubing sets and equipment, light sources and fiber optic components, sterilization trays and containers, and comprehensive preventive maintenance and repair services. Representative recent awards include a $8.5 million delivery order from VA's Veterans Integrated Service Network 9 (July 2026) for the Karl Storz Collaborator Interactive Platform under the GSA Federal Supply Schedule FSS-65-II-A; a $1.47 billion delivery order from Defense Logistics Agency Medical Supply Chain (June 2026) for IOR system equipment under the DLA MSC Patient Monitoring parent contract; a $10.08 billion delivery order from DLA Medical Supply Chain (June 2026) for additional IOR systems; a $655 thousand purchase order from VA Veterans Integrated Service Network 8 (September 2026) for OES technician services; and a $1.09 billion delivery order from VA Veterans Integrated Service Network 7 (June 2026) for operating room surgical instruments under FSS-65-II-A.

Customer concentration is extreme and anchored by a single customer. The Defense Logistics Agency Troop Support Medical accounts for 11,468 awards (54.7% of total) and $2.83 billion (80.2% of combined potential value), overwhelming all other federal customers. The Department of Veterans Affairs networks collectively hold the second-largest share: VA Veterans Integrated Service Network 12 places 199 awards worth $328.6 million, VA Veterans Integrated Service Network 8 places 260 awards worth $41.4 million, VA Veterans Integrated Service Network 10 places 516 awards worth $22.5 million, and VA Veterans Integrated Service Network 17 places 103 awards worth $24.8 million. The Department of the Navy Bureau of Medicine and Surgery (607 awards, $22.5 million) and the Department of the Army Medical Command (425 awards, $29.2 million) represent supplementary customers. Across 80 distinct federal agencies, these five largest customers account for 63% of all awards and represent 92% of combined potential value.

The vendor holds a $171 million indefinite-delivery/indefinite-quantity Federal Supply Schedule contract (FSS-65-II-A for Medical Equipment and Supplies) awarded by the Department of Veterans Affairs effective September 1, 2023, through August 31, 2028, which is actively utilized across Veterans Integrated Service Networks and Indian Health Service. Beyond FSS-65-II-A, the vendor places the majority of its volume through three DLA parent vehicles: Indefinite Delivery Contract SPE2D120D7007 (5,722 task orders, $48.6 million combined potential value), DLA Medical Capital Equipment Program (5,595 task orders, $53.2 million combined potential value), and Federal Supply Schedule V797P4512A (4,505 task orders, $117.7 million combined potential value). Together these three vehicles account for roughly half of all task orders.

Award volume has moderated slightly but remains substantial. The vendor placed 1,236 awards in 2024, 1,124 in 2025, and 710 through September 2026 (on track for roughly 950 for the full fiscal year). Combined potential value across the 20,955 total awards sits at $3.53 billion, with only $532.9 million obligated to date (15% obligation rate, typical for supply schedules). The recompete window shows 44 awards with completion dates in the next twenty-four months carrying $39.2 million in combined potential value—a modest cliff relative to the vendor's scale.

SCI-reported service-contract activity presents a partial and minimal subset of the vendor's federal footprint. Service Contract Inventory captures federal service contracts above the $150,000 threshold, excluding goods, products, and micro-purchases. Karl Storz Endoscopy-America reported $10.6 million across 45 SCI records spanning FY2023–FY2025 (zero in FY2022), with $1.9 million invoiced in FY2023 across 13.0 FTEs, $5 million in FY2024 across 27.1 FTEs, and $3.8 million in FY2025 across 14.9 FTEs. Across these SCI-reportable prime contracts, median government-paid hourly rates ran around $52.25/hr, with pricing ranging from a 10th-percentile floor of $25.73/hr to a 90th-percentile ceiling of $90.02/hr. SCI shows zero subcontractor engagement; the vendor performs all SCI-reportable work directly. These service dollars are a negligible share of Karl Storz's $3.53 billion federal portfolio, which is overwhelmingly goods-based (endoscopy equipment, instruments, and supplies), and SCI figures themselves represent a strict subset of federal revenue and a smaller fraction of the parent company's total enterprise revenue.

The vendor operates as a pure prime on federal supply schedules with no teaming or subcontracting footprint, competing on full-and-open vehicles without set-aside certifications. Across its 20,955 awards, 100% are prime; zero are sub-awards. The corporate structure identifies Karl Storz GmbH & Co. KG as the parent entity, with Karl Storz Endoscopy-America Inc. as the U.S. subsidiary executing federal contracts.